Exosome Diagnostics
Cheryl Amadi is an experienced professional currently working as an Accessioning Technologist at Exosome Diagnostics since January 2023. Previously, Cheryl held the position of Care Manager at Sunrise Senior Living from July 2020 to January 2022 and served as an Orientation Leader and Work Study at North Shore Community College from September 2017 to January 2020. Cheryl's early experience includes working as a Customer Service Associate at Walmart from June 2016 to September 2019. Academically, Cheryl earned a Bachelor of Applied Science in Bioengineering and Biomedical Engineering from the University of Massachusetts Amherst in May 2022, following an Associate of Arts in Liberal Arts and Sciences from North Shore Community College in September 2019.
This person is not in any offices
Exosome Diagnostics
Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technologymakes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.